New York, January 16, 2019— Creative Biolabs, a trustworthy antibody provider located in New York, now provides high-quality recombinant antibodies to support prostate cancer.
As the second leading cause of cancer death in American men, behind lung cancer, prostate cancer (PCa) predominately affects elderly men with higher incidence, which are often found early by testing for prostate-specific antigen (PSA) levels in a man’s blood. The traditional diagnosis methods generally contribute to multiple side-effects, such as a poor prognosis or systemic recurrence of cancers. Therefore, it’s significant to optimize early diagnosis and develop targeted therapy of prostate cancer to improving the benefit of screening and the survival rate of patients.
In the treatment of prostate cancer, androgen receptor is vital for the development and physiology of the prostate gland, and also cancer progression and therefore blocking AR activity or lowering androgen levels is closely related to androgen deprivation therapy (ADT). In-depth understanding of AR signaling and the mechanisms of castration resistance in PCa has resulted in the development of novel agents that can more efficiently retract AR signaling. In Creative Biolabs, the best-suitable androgen receptor antibody is selected for your research based on antibody subtype, antigenic determinant, application and species reactivity, which are applied to flow cytometry, ICC / IF, IHC-P, WB, etc.
In addition, NF-κB refers to a protein complex regulating expression of key genes required for innate and adaptive immunity, lymphoid organ development and cell proliferation and survival. Preclinical studies in prostate cancer xenografts have firmly established that blockade of receptor activator of NF-κB (RANK) signal instigated by binding of RANK ligands (RANK-L) impairs the establishment and progression of bone metastasis. Recombinant nfkb antibody offered by Creative Biolabs has excellent effects. Immunogen-specific antibody genes are cloned into high-quality antibodies developed in high-level mammalian expression vectors by immunizing animals and screening functions, which are suitable for IHC-FoFr, ICC / IF, IHC-P, WB, IP, Flow Cyt.
Equipped with a comprehensive list of antibodies for different research fields and applications, Creative Biolabs is confident to select the best antibody to meet each unique need of global clients. For more detailed information, please visit https://www.antibody-creativebiolabs.com.
Author Bio
Since 2004, Creative Biolabs has been dedicated to providing high-quality services to the academic and life sciences worldwide. In the past decade, Creative Biolabs become the leader in the discovery and manufacture of recombinant antibodies. A custom-service-centered business model is crucial for optimizing the drug development process, leveraging accessible resources, and gathering a team from various backgrounds to conduct drug discovery projects in the future. As the preferred supplier for global customers, scientists in Creative Biolabs are confident to provide customers with first-class services covering a full range of applications.
Media ContactCompany Name: Creative BiolabsContact Person: Bella SmithEmail: Send EmailPhone: 1-631-619-7922Address:45-1 Ramsey Road City: ShirleyState: New YorkCountry: United StatesWebsite: https://www.antibody-creativebiolabs.com
